The US synthetic biology market is anticipated to grow at a CAGR of 31.8% during the forecast period. The synthetic biology market in the US is driven by extensive funding by government officials, increasing number of companies in the field of synthetic biology and technological advancements in the life science sector. Since the beginning of synthetic biology, the US has been conducting synthetic biology research for more than 15 years and has made progress. The US is the largest investor in public research funding and it continues to increase its investment in order to maintain its position at the global level.
To Request a Sample of our Report on United States Synthetic Biology Market: https://www.omrglobal.com/request-sample/us-synthetic-biology-market
Large-scale integrated programs are being funded by the government agencies such as the NSF and DARPA to innovate solutions for sustainable development. Furthermore, the increasing roadmap studies in synthetic biology by the US is promoting R&D in synthetic biology. Road-map studies enable R&D strategies to address key challenges and enable innovative applications. It is anticipated that with the sustainable strategic investment from the US government agencies, synthetic biology will continue to thrive in both basic and applied research in the US.
The US synthetic biology market is segmented on the basis of product, technology, and applications. Based on the product, the market is segmented into enabling products, core products, and enabled products. Core product includes synthetic genes, synthetic cells, synthetic DNA, chassis organisms and Xeno Nucleic Acid (XNA), and are expected to hold a significant share in the market owing to extensive use of core products in R&D. Based on technology, the market is segmented into, and gene synthesis & sequencing, genome engineering, bioinformatics, and others. Based on application, the market is segmented into medical applications, industrial applications, food & agriculture, and environmental applications.
(Get 15% Discount on Buying this Report)
A full Report of United States Synthetic Biology Market is Available @ https://www.omrglobal.com/industry-reports/us-synthetic-biology-market
United States Synthetic Biology Market Segmentation
By Product
- Enabling Product
- Core Product
- Enabled Product
By Technology
- Gene Synthesis & Sequencing
- Genome Engineering
- Bioinformatics
- Others
By Application
- Medical Application
- Industrial Application
- Food & Agriculture
- Environmental Application
Company Profiles
- Algenol
- Amyris, Inc.
- Butamax Advanced Biofuels LLC
- Codexis, Inc.
- DNA TwoPointO, Inc. (ATUM)
- E. I. du Pont de Nemours and Co.
- Editas Medicine, Inc.
- Genewiz, Inc.
- GenScript Biotech Corp.
- Intellia Therapeutics, Inc.
- Integrated DNA Technologies, Inc.
- Merck KGaA
- OriGene Technologies, Inc.
- Synthetic Genomics, Inc.
- Synthorx, Inc.
- Thermo Fisher Scientific, Inc.
- Twist Bioscience Corp.
- Vedanta Biosciences, Inc.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
